Kv7.3

1

Schütze S et al. KCNQ Potassium Channels Modulate Sensitivity of Skin D-hair Mechanoreceptors.
J. Biol. Chem., 2016 Jan 5 , ().

2

Subramani B et al. Generation and characterization of human cardiac resident and non-resident mesenchymal stem cell.
Cytotechnology, 2016 Jan 28 , ().

3

Syeda R et al. The Sensorless Pore Module of Voltage-gated K+ Channel Family 7 Embodies the Target Site for the Anticonvulsant Retigabine.
J. Biol. Chem., 2016 Feb 5 , 291 (2931-7).

4

Benned-Jensen T et al. Live Imaging of Kv7.2/7.3 Cell Surface Dynamics at the Axon Initial Segment: High Steady-State Stability and Calpain-Dependent Excitotoxic Downregulation Revealed.
J. Neurosci., 2016 Feb 17 , 36 (2261-6).

5

Kim KX et al. Maturation of NaV and KV Channel Topographies in the Auditory Nerve Spike Initiator before and after Developmental Onset of Hearing Function.
J. Neurosci., 2016 Feb 17 , 36 (2111-8).

6

Siloni S et al. Regulation of the neuronal KCNQ2 channel by Src--a dual rearrangement of the cytosolic termini underlies bidirectional regulation of gating.
J. Cell. Sci., 2015 Sep 15 , 128 (3489-501).

7

Provence A et al. The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility.
J. Pharmacol. Exp. Ther., 2015 Sep , 354 (290-301).

8

Jiang L et al. Activation of m1 muscarinic acetylcholine receptor induces surface transport of KCNQ channel via CRMP-2 mediated pathway.
J. Cell. Sci., 2015 Oct 7 , ().

9

Hamada MS et al. Myelin loss and axonal ion channel adaptations associated with gray matter neuronal hyperexcitability.
J. Neurosci., 2015 May 6 , 35 (7272-86).

10

Kaminsky Z et al. DNA methylation and expression of KCNQ3 in bipolar disorder.
Bipolar Disord, 2015 Mar , 17 (150-9).

11

Mills TA et al. Activation of KV7 channels stimulates vasodilatation of human placental chorionic plate arteries.
Placenta, 2015 Jun , 36 (638-44).

12

Xu M et al. An Ankyrin-G N-terminal Gate and Protein Kinase CK2 Dually Regulate Binding of Voltage-gated Sodium and KCNQ2/3 Potassium Channels.
J. Biol. Chem., 2015 Jul 3 , 290 (16619-32).

13

Grinton BE et al. Familial neonatal seizures in 36 families: Clinical and genetic features correlate with outcome.
Epilepsia, 2015 Jul , 56 (1071-80).

14

Fusco C et al. A novel KCNQ3 gene mutation in a child with infantile convulsions and partial epilepsy with centrotemporal spikes.
Eur. J. Paediatr. Neurol., 2015 Jan , 19 (102-3).

15

Miceli F et al. A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability.
Epilepsia, 2015 Feb , 56 (e15-20).

16

Wang J et al. Functional analysis of potassium channels in Kv7.2 G271V mutant causing early onset familial epilepsy.
Brain Res., 2015 Aug 7 , 1616 (112-22).

17

Abidi A et al. A recurrent KCNQ2 pore mutation causing early onset epileptic encephalopathy has a moderate effect on M current but alters subcellular localization of Kv7 channels.
Neurobiol. Dis., 2015 Aug , 80 (80-92).

18

Li C et al. Activity-dependent downregulation of M-Type (Kv7) K⁺ channels surface expression requires the activation of iGluRs/Ca²⁺/PKC signaling pathway in hippocampal neuron.
Neuropharmacology, 2015 Aug , 95 (154-67).

19

Svalø J et al. Functional and molecular evidence for Kv7 channel subtypes in human detrusor from patients with and without bladder outflow obstruction.
PLoS ONE, 2015 , 10 (e0117350).

20

Fidzinski P et al. KCNQ5 K(+) channels control hippocampal synaptic inhibition and fast network oscillations.
Nat Commun, 2015 , 6 (6254).

21

Zhang F et al. Inhibition of Kv7/M Channel Currents by the Local Anesthetic Chloroprocaine.
Pharmacology, 2015 , 96 (124-30).

22

Allen NM et al. The variable phenotypes of KCNQ-related epilepsy.
Epilepsia, 2014 Sep , 55 (e99-105).

23

Grigorov A et al. Kv7 potassium channel subunits and M currents in cultured hippocampal interneurons.
Pflugers Arch., 2014 Sep , 466 (1747-58).

24

King CH et al. Kv7.2 regulates the function of peripheral sensory neurons.
J. Comp. Neurol., 2014 Oct 1 , 522 (3262-80).

25

Li C et al. KCNQ/Kv7 channel activator flupirtine protects against acute stress-induced impairments of spatial memory retrieval and hippocampal LTP in rats.
Neuroscience, 2014 Nov 7 , 280 (19-30).

26

Schleifenbaum J et al. Stretch-Activation of Angiotensin II Type 1a Receptors Contributes to the Myogenic Response of Mouse Mesenteric and Renal Arteries.
Circ. Res., 2014 May 16 , ().

27

Wang L et al. CAMK1 Phosphoinositide Signal-Mediated Protein Sorting and Transport Network in Human Hepatocellular Carcinoma (HCC) by Biocomputation.
Cell Biochem. Biophys., 2014 May 14 , ().

28

Mistry HD et al. Expression of voltage-dependent potassium channels in first trimester human placentae.
Placenta, 2014 May , 35 (337-40).

29

Brueggemann LI et al. KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways.
Am. J. Physiol. Lung Cell Mol. Physiol., 2014 Mar 15 , 306 (L476-86).

30

Orhan G et al. Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy.
Ann. Neurol., 2014 Mar , 75 (382-94).

31

Soldovieri MV et al. Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A.
Hum. Mutat., 2014 Mar , 35 (356-67).

32

Liu W et al. Calmodulin orchestrates the heteromeric assembly and the trafficking of KCNQ2/3 (Kv7.2/3) channels in neurons.
Mol. Cell. Neurosci., 2014 Jan , 58 (40-52).

33

Gourgy-Hacohen O et al. Capturing distinct KCNQ2 channel resting states by metal ion bridges in the voltage-sensor domain.
J. Gen. Physiol., 2014 Dec , 144 (513-27).

34

Soh H et al. Conditional deletions of epilepsy-associated KCNQ2 and KCNQ3 channels from cerebral cortex cause differential effects on neuronal excitability.
J. Neurosci., 2014 Apr 9 , 34 (5311-21).

35

Wu C et al. Kcnq1-5 (Kv7.1-5) potassium channel expression in the adult zebrafish.
BMC Physiol., 2014 , 14 (1).

36

Maljevic S et al. Potassium channel genes and benign familial neonatal epilepsy.
Prog. Brain Res., 2014 , 213 (17-53).

37

Cavaretta JP et al. Polarized axonal surface expression of neuronal KCNQ potassium channels is regulated by calmodulin interaction with KCNQ2 subunit.
PLoS ONE, 2014 , 9 (e103655).

38

Svalø J et al. Bladder contractility is modulated by Kv7 channels in pig detrusor.
Eur. J. Pharmacol., 2013 Sep 5 , 715 (312-20).

39

Chen CP et al. An interstitial deletion of 8q23.3-q24.22 associated with Langer-Giedion syndrome, Cornelia de Lange syndrome and epilepsy.
Gene, 2013 Oct 15 , 529 (176-80).

40

Zhou P et al. Phosphatidylinositol 4,5-bisphosphate alters pharmacological selectivity for epilepsy-causing KCNQ potassium channels.
Proc. Natl. Acad. Sci. U.S.A., 2013 May 21 , 110 (8726-31).

41

Fister P et al. Benign familial neonatal convulsions caused by mutation in KCNQ3, exon 6: a European case.
Eur. J. Paediatr. Neurol., 2013 May , 17 (308-10).

42

Zara F et al. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance.
Epilepsia, 2013 Mar , 54 (425-36).

43

Zheng Q et al. Suppression of KCNQ/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model.
Pain, 2013 Mar , 154 (434-48).

44

Boehlen A et al. The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-yl)-benzamid displays anticonvulsant potential.
Br. J. Pharmacol., 2013 Mar , 168 (1182-200).

45

Füll Y et al. A conserved threonine in the S1-S2 loop of KV7.2 and K V7.3 channels regulates voltage-dependent activation.
Pflugers Arch., 2013 Jun , 465 (797-804).

46

Miranda P et al. The neuronal serum- and glucocorticoid-regulated kinase 1.1 reduces neuronal excitability and protects against seizures through upregulation of the M-current.
J. Neurosci., 2013 Feb 6 , 33 (2684-96).

47

Maslarova A et al. Increased susceptibility to acetylcholine in the entorhinal cortex of pilocarpine-treated rats involves alterations in KCNQ channels.
Neurobiol. Dis., 2013 Aug , 56 (14-24).

48

Lichter-Peled A et al. Role of KCNQ2 and KCNQ3 genes in juvenile idiopathic epilepsy in Arabian foals.
Vet. J., 2013 Apr , 196 (57-63).

49

Judy JT et al. Converging Evidence for Epistasis between ANK3 and Potassium Channel Gene KCNQ2 in Bipolar Disorder.
Front Genet, 2013 , 4 (87).

50

Afeli SA et al. Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscle.
PLoS ONE, 2013 , 8 (e75875).

51

Robbins J et al. Effects of KCNQ2 gene truncation on M-type Kv7 potassium currents.
PLoS ONE, 2013 , 8 (e71809).

52

Kosenko A et al. A change in configuration of the calmodulin-KCNQ channel complex underlies Ca2+-dependent modulation of KCNQ channel activity.
PLoS ONE, 2013 , 8 (e82290).

53

Ferrer T et al. Tamoxifen inhibition of kv7.2/kv7.3 channels.
PLoS ONE, 2013 , 8 (e76085).

54

Afawi Z et al. Benign neonatal sleep myoclonus: an autosomal dominant form not allelic to KCNQ2 or KCNQ3.
J. Child Neurol., 2012 Oct , 27 (1260-3).

55

Ishii A et al. KCNQ2 abnormality in BECTS: benign childhood epilepsy with centrotemporal spikes following benign neonatal seizures resulting from a mutation of KCNQ2.
Epilepsy Res., 2012 Nov , 102 (122-5).

56

Telezhkin V et al. Structural requirements of membrane phospholipids for M-type potassium channel activation and binding.
J. Biol. Chem., 2012 Mar 23 , 287 (10001-12).

57

Hobiger K et al. Coupling of Ci-VSP modules requires a combination of structure and electrostatics within the linker.
Biophys. J., 2012 Mar 21 , 102 (1313-22).

58

Pattnaik BR et al. Effects of KCNQ channel modulators on the M-type potassium current in primate retinal pigment epithelium.
Am. J. Physiol., Cell Physiol., 2012 Mar , 302 (C821-33).

59

Choveau FS et al. Pore helix-S6 interactions are critical in governing current amplitudes of KCNQ3 K+ channels.
Biophys. J., 2012 Jun 6 , 102 (2499-509).

60

Choveau FS et al. Pore determinants of KCNQ3 K+ current expression.
Biophys. J., 2012 Jun 6 , 102 (2489-98).

61

Ebner-Bennatan S et al. Multi-faceted modulation of K+ channels by protein tyrosine phosphatase epsilon tunes neuronal excitability.
, 2012 Jun 21 , ().

62

King CH et al. Kv7.5 is the primary Kv7 subunit expressed in C-fibers.
J. Comp. Neurol., 2012 Jun 15 , 520 (1940-50).

63

Telezhkin V et al. Distinct subunit contributions to the activation of M-type potassium channels by PI(4,5)P2.
J. Gen. Physiol., 2012 Jul , 140 (41-53).

64

Weckhuysen S et al. KCNQ2 encephalopathy: emerging phenotype of a neonatal epileptic encephalopathy.
Ann. Neurol., 2012 Jan , 71 (15-25).

65

Linley JE et al. M channel enhancers and physiological M channel block.
J. Physiol. (Lond.), 2012 Feb 15 , 590 (793-807).

66

Chege SW et al. Expression and function of KCNQ channels in larval zebrafish.
Dev Neurobiol, 2012 Feb , 72 (186-98).

67

Stewart AP et al. The Kv7.2/Kv7.3 heterotetramer assembles with a random subunit arrangement.
J. Biol. Chem., 2012 Apr 6 , 287 (11870-7).

68

Chadha PS et al. Reduced KCNQ4-encoded voltage-dependent potassium channel activity underlies impaired β-adrenoceptor-mediated relaxation of renal arteries in hypertension.
Hypertension, 2012 Apr , 59 (877-84).

69

Aivar P et al. Surface expression and subunit specific control of steady protein levels by the Kv7.2 helix A-B linker.
PLoS ONE, 2012 , 7 (e47263).

70

Kim JB et al. Expression patterns of two potassium channel genes in skeletal muscle cells of patients with familial hypokalemic periodic paralysis.
Neurol India, 2011 Jul-Aug , 59 (527-31).

71

Mistry HD et al. Novel expression and regulation of voltage-dependent potassium channels in placentas from women with preeclampsia.
Hypertension, 2011 Sep , 58 (497-504).

72

Etzioni A et al. Regulation of neuronal M-channel gating in an isoform-specific manner: functional interplay between calmodulin and syntaxin 1A.
J. Neurosci., 2011 Oct 5 , 31 (14158-71).

73

Klinger F et al. Distribution of M-channel subunits KCNQ2 and KCNQ3 in rat hippocampus.
Neuroimage, 2011 Oct 1 , 58 (761-9).

74

Du X et al. Characteristics and molecular basis of celecoxib modulation on Kv7 potassium channels.
, 2011 May 13 , ().

75

Zhang J et al. AKAP79/150 Signal Complexes in G-Protein Modulation of Neuronal Ion Channels.
J. Neurosci., 2011 May 11 , 31 (7199-211).

76

McCallum LA et al. The contribution of Kv7 channels to pregnant mouse and human myometrial contractility.
J. Cell. Mol. Med., 2011 Mar , 15 (577-86).

77

Zhou X et al. Potential role of KCNQ/M-channels in regulating neuronal differentiation in mouse hippocampal and embryonic stem cell-derived neuronal cultures.
Exp. Neurol., 2011 Jun , 229 (471-83).

78

Fontán-Lozano A et al. The M-current inhibitor XE991 decreases the stimulation threshold for long-term synaptic plasticity in healthy mice and in models of cognitive disease.
Hippocampus, 2011 Jan , 21 (22-32).

79

Roepke TA et al. Fasting and 17β-estradiol differentially modulate the M-current in neuropeptide Y neurons.
J. Neurosci., 2011 Aug 17 , 31 (11825-35).

80

Cooper EC Made for "anchorin": Kv7.2/7.3 (KCNQ2/KCNQ3) channels and the modulation of neuronal excitability in vertebrate axons.
Semin. Cell Dev. Biol., 2011 Apr , 22 (185-92).

81

Gao Z et al. Isoform-specific Prolongation of Kv7 (KCNQ) Potassium Channel Opening Mediated by New Molecular Determinants for Drug-Channel Interactions.
J. Biol. Chem., 2010 Sep 3 , 285 (28322-32).

82

Zhong XZ et al. Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter.
J. Physiol. (Lond.), 2010 Sep 1 , 588 (3277-93).

83

Heron SE et al. Familial neonatal seizures with intellectual disability caused by a microduplication of chromosome 2q24.3.
Epilepsia, 2010 Sep , 51 (1865-9).

84

Mucha M et al. Transcriptional control of KCNQ channel genes and the regulation of neuronal excitability.
J. Neurosci., 2010 Oct 6 , 30 (13235-45).

85

Lötsch J et al. Pharmacogenetics of new analgesics.
, 2010 Oct 13 , ().

86

Tzingounis AV et al. The KCNQ5 potassium channel mediates a component of the afterhyperpolarization current in mouse hippocampus.
Proc. Natl. Acad. Sci. U.S.A., 2010 Jun 1 , 107 (10232-7).

87

Gómez-Posada JC et al. A pore residue of the KCNQ3 potassium M-channel subunit controls surface expression.
J. Neurosci., 2010 Jul 7 , 30 (9316-23).

88

Yum MS et al. The first Korean case of KCNQ2 mutation in a family with benign familial neonatal convulsions.
J. Korean Med. Sci., 2010 Feb , 25 (324-6).

89

Serratrice G et al. [Potassium channelopathies and Morvan's syndromes].
Bull. Acad. Natl. Med., 2010 Feb , 194 (391-406; discussion 406-7).

90

Baulac S et al. Advances on the genetics of mendelian idiopathic epilepsies.
Clin. Lab. Med., 2010 Dec , 30 (911-29).

91

Zhang P et al. Family-based association analysis to finemap bipolar linkage peak on chromosome 8q24 using 2,500 genotyped SNPs and 15,000 imputed SNPs.
Bipolar Disord, 2010 Dec , 12 (786-92).

92

Soh H et al. The specific slow afterhyperpolarization inhibitor UCL2077 is a subtype-selective blocker of the epilepsy associated KCNQ channels.
Mol. Pharmacol., 2010 Dec , 78 (1088-95).

93

Heron SE et al. Neonatal seizures and Long QT Syndrome: A cardiocerebral channelopathy?
Epilepsia, 2009 Oct 27 , ().

94

Volkers L et al. Functional analysis of novel KCNQ2 mutations found in patients with Benign Familial Neonatal Convulsions.
Neurosci. Lett., 2009 Oct 2 , 462 (24-9).

95

Kurahashi H et al. Deletions involving both KCNQ2 and CHRNA4 present with benign familial neonatal seizures.
Neurology, 2009 Oct 13 , 73 (1214-7).

96

Padilla K et al. The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site.
Neurosci. Lett., 2009 Nov 13 , 465 (138-42).

97

Goldberg-Stern H et al. Novel mutation in KCNQ2 causing benign familial neonatal seizures.
Pediatr. Neurol., 2009 Nov , 41 (367-70).

98

Baulac S et al. Advances on the genetics of mendelian idiopathic epilepsies.
Neurol Clin, 2009 Nov , 27 (1041-61).

99

Hernandez CC et al. Affinity for phosphatidylinositol 4,5-bisphosphate determines muscarinic agonist sensitivity of Kv7 K+ channels.
J. Gen. Physiol., 2009 Nov , 134 (437-48).

100

Sugiura Y et al. Lack of potassium current in W309R mutant KCNQ3 channel causing benign familial neonatal convulsions (BFNC).
Epilepsy Res., 2009 Mar , 84 (82-5).

101

Namkung W et al. In situ measurement of airway surface liquid [K+] using a ratioable K+-sensitive fluorescent dye.
J. Biol. Chem., 2009 Jun 5 , 284 (15916-26).

102

Miceli F et al. Neutralization of a unique, negatively-charged residue in the voltage sensor of K V 7.2 subunits in a sporadic case of benign familial neonatal seizures.
Neurobiol. Dis., 2009 Jun , 34 (501-10).

103

Otto JF et al. Electroconvulsive seizure thresholds and kindling acquisition rates are altered in mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions.
Epilepsia, 2009 Jul , 50 (1752-9).

104

Greenwood IA et al. KCNQ-encoded channels regulate Na+ transport across H441 lung epithelial cells.
Pflugers Arch., 2009 Feb , 457 (785-94).

105

Lange W et al. Refinement of the binding site and mode of action of the anticonvulsant Retigabine on KCNQ K+ channels.
Mol. Pharmacol., 2009 Feb , 75 (272-80).

106

de Mooij-van Malsen AJ et al. Interspecies trait genetics reveals association of Adcy8 with mouse avoidance behavior and a human mood disorder.
Biol. Psychiatry, 2009 Dec 15 , 66 (1123-30).

107

Hahn A et al. Sodium and potassium channel dysfunctions in rare and common idiopathic epilepsy syndromes.
Brain Dev., 2009 Aug , 31 (515-20).

108

Brown DA et al. Neural KCNQ (Kv7) channels.
Br. J. Pharmacol., 2009 Apr , 156 (1185-95).

109

Jin Z et al. Expression and localization of K channels KCNQ2 and KCNQ3 in the mammalian cochlea.
Audiol. Neurootol., 2009 , 14 (98-105).

110

Wickenden AD et al. Kv7 channels as targets for the treatment of pain.
Curr. Pharm. Des., 2009 , 15 (1773-98).

111

Roura-Ferrer M et al. Functional implications of KCNE subunit expression for the Kv7.5 (KCNQ5) channel.
Cell. Physiol. Biochem., 2009 , 24 (325-34).

112

Regev N et al. Selective interaction of syntaxin 1A with KCNQ2: possible implications for specific modulation of presynaptic activity.
PLoS ONE, 2009 , 4 (e6586).

113

Roeloffs R et al. In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models.
J. Pharmacol. Exp. Ther., 2008 Sep , 326 (818-28).

114

Hernandez CC et al. A carboxy-terminal inter-helix linker as the site of phosphatidylinositol 4,5-bisphosphate action on Kv7 (M-type) K+ channels.
J. Gen. Physiol., 2008 Sep , 132 (361-81).

115

Bal M et al. Homomeric and heteromeric assembly of KCNQ (Kv7) K+ channels assayed by total internal reflection fluorescence/fluorescence resonance energy transfer and patch clamp analysis.
J. Biol. Chem., 2008 Nov 7 , 283 (30668-76).

116

Nyholt DR et al. A high-density association screen of 155 ion transport genes for involvement with common migraine.
Hum. Mol. Genet., 2008 Nov 1 , 17 (3318-31).

117

Bal M et al. Calmodulin binding to M-type K+ channels assayed by TIRF/FRET in living cells.
J. Physiol. (Lond.), 2008 May 1 , 586 (2307-20).

118

Kanaumi T et al. Developmental changes in KCNQ2 and KCNQ3 expression in human brain: possible contribution to the age-dependent etiology of benign familial neonatal convulsions.
Brain Dev., 2008 May , 30 (362-9).

119

Wickenden AD et al. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator.
Mol. Pharmacol., 2008 Mar , 73 (977-86).

120

Liu B et al. Antihistamine mepyramine directly inhibits KCNQ/M channel and depolarizes rat superior cervical ganglion neurons.
Neuropharmacology, 2008 Mar , 54 (629-39).

121

Li H et al. A novel mutation of KCNQ3 gene in a Chinese family with benign familial neonatal convulsions.
Epilepsy Res., 2008 Mar , 79 (1-5).

122

Uehara A et al. Altered KCNQ3 potassium channel function caused by the W309R pore-helix mutation found in human epilepsy.
J. Membr. Biol., 2008 Mar , 222 (55-63).

123

Shah MM et al. Functional significance of axonal Kv7 channels in hippocampal pyramidal neurons.
Proc. Natl. Acad. Sci. U.S.A., 2008 Jun 3 , 105 (7869-74).

124

Nakajo K et al. Second coiled-coil domain of KCNQ channel controls current expression and subfamily specific heteromultimerization by salt bridge networks.
J. Physiol. (Lond.), 2008 Jun 15 , 586 (2827-40).

125

Singh NA et al. Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization.
J. Physiol. (Lond.), 2008 Jul 15 , 586 (3405-23).

126

Neubauer BA et al. KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes.
Neurology, 2008 Jul 15 , 71 (177-83).

127

Schuetz F et al. Regulation of the voltage-gated K(+) channels KCNQ2/3 and KCNQ3/5 by serum- and glucocorticoid-regulated kinase-1.
Am. J. Physiol., Cell Physiol., 2008 Jul , 295 (C73-80).

128

Fedorenko O et al. A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels.
Psychopharmacology (Berl.), 2008 Jul , 199 (47-54).

129

Wuttke TV et al. Neutralization of a negative charge in the S1-S2 region of the KV7.2 (KCNQ2) channel affects voltage-dependent activation in neonatal epilepsy.
J. Physiol. (Lond.), 2008 Jan 15 , 586 (545-55).

130

Xiong Q et al. Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers.
Proc. Natl. Acad. Sci. U.S.A., 2008 Feb 26 , 105 (3128-33).

131

Wladyka CL et al. The KCNQ/M-current modulates arterial baroreceptor function at the sensory terminal in rats.
J. Physiol. (Lond.), 2008 Feb 1 , 586 (795-802).

132

Miceli F et al. Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs.
, 2008 Feb , 8 (65-74).

133

Moser SL et al. Multiple KCNQ potassium channel subtypes mediate basal anion secretion from the human airway epithelial cell line Calu-3.
J. Membr. Biol., 2008 Feb , 221 (153-63).

134

Tzingounis AV et al. Contribution of KCNQ2 and KCNQ3 to the medium and slow afterhyperpolarization currents.
Proc. Natl. Acad. Sci. U.S.A., 2008 Dec 16 , 105 (19974-9).

135

Zaika O et al. Determinants within the turret and pore-loop domains of KCNQ3 K+ channels governing functional activity.
Biophys. J., 2008 Dec , 95 (5121-37).

136

Hansen HH et al. Kv7 channels: interaction with dopaminergic and serotonergic neurotransmission in the CNS.
J. Physiol. (Lond.), 2008 Apr 1 , 586 (1823-32).

137

Hernandez CC et al. Regulation of neural KCNQ channels: signalling pathways, structural motifs and functional implications.
J. Physiol. (Lond.), 2008 Apr 1 , 586 (1811-21).

138

Maljevic S et al. Nervous system KV7 disorders: breakdown of a subthreshold brake.
J. Physiol. (Lond.), 2008 Apr 1 , 586 (1791-801).

139

Sadewa AH et al. Germ-line mutation of KCNQ2, p.R213W, in a Japanese family with benign familial neonatal convulsion.
Pediatr Int, 2008 Apr , 50 (167-71).

140

Yalçin O et al. A novel missense mutation (N258S) in the KCNQ2 gene in a Turkish family afflicted with benign familial neonatal convulsions (BFNC).
Turk. J. Pediatr., 2007 Oct-Dec , 49 (385-9).

141

Soldovieri MV et al. Correlating the clinical and genetic features of benign familial neonatal seizures (BFNS) with the functional consequences of underlying mutations.
Channels (Austin), 2007 Jul-Aug , 1 (228-33).

142

Lucarini N et al. Genetic polymorphisms and idiopathic generalized epilepsies.
Pediatr. Neurol., 2007 Sep , 37 (157-64).

143

Roepke TA et al. Estrogen regulation of genes important for K+ channel signaling in the arcuate nucleus.
Endocrinology, 2007 Oct , 148 (4937-51).

144

Qiu C et al. K+ M-current regulates the transition to seizures in immature and adult hippocampus.
Epilepsia, 2007 Nov , 48 (2047-58).

145

Bai X et al. Electrophysiological properties of human adipose tissue-derived stem cells.
Am. J. Physiol., Cell Physiol., 2007 Nov , 293 (C1539-50).

146

Soldovieri MV et al. Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions.
J. Neurosci., 2007 May 2 , 27 (4919-28).

147

Xiong Q et al. Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants.
Nat. Chem. Biol., 2007 May , 3 (287-96).

148

Rasmussen HB et al. Requirement of subunit co-assembly and ankyrin-G for M-channel localization at the axon initial segment.
J. Cell. Sci., 2007 Mar 15 , 120 (953-63).

149

Martire M et al. Involvement of KCNQ2 subunits in [3H]dopamine release triggered by depolarization and pre-synaptic muscarinic receptor activation from rat striatal synaptosomes.
J. Neurochem., 2007 Jul , 102 (179-93).

150

Heron SE et al. Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures.
J. Med. Genet., 2007 Dec , 44 (791-6).

151

Brown DA et al. Regulation of M(Kv7.2/7.3) channels in neurons by PIP(2) and products of PIP(2) hydrolysis: significance for receptor-mediated inhibition.
J. Physiol. (Lond.), 2007 Aug 1 , 582 (917-25).

152

Ekberg J et al. Regulation of the voltage-gated K(+) channels KCNQ2/3 and KCNQ3/5 by ubiquitination. Novel role for Nedd4-2.
J. Biol. Chem., 2007 Apr 20 , 282 (12135-42).

153

Jensen HS et al. Inactivation as a new regulatory mechanism for neuronal Kv7 channels.
Biophys. J., 2007 Apr 15 , 92 (2747-56).

154

Zhou X et al. Infantile seizures and other epileptic phenotypes in a Chinese family with a missense mutation of KCNQ2.
Eur. J. Pediatr., 2006 Oct , 165 (691-5).

155

Hunter J et al. Subthreshold changes of voltage-dependent activation of the K(V)7.2 channel in neonatal epilepsy.
Neurobiol. Dis., 2006 Oct , 24 (194-201).

156

Lawrence JJ et al. Somatodendritic Kv7/KCNQ/M channels control interspike interval in hippocampal interneurons.
J. Neurosci., 2006 Nov 22 , 26 (12325-38).

157

Bentzen BH et al. The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels.
Neuropharmacology, 2006 Nov , 51 (1068-77).

158

Geiger J et al. Immunohistochemical analysis of KCNQ3 potassium channels in mouse brain.
Neurosci. Lett., 2006 May 29 , 400 (101-4).

159

Schwarz JR et al. KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier.
J. Physiol. (Lond.), 2006 May 15 , 573 (17-34).

160

de Haan GJ et al. A novel splicing mutation in KCNQ2 in a multigenerational family with BFNC followed for 25 years.
Epilepsia, 2006 May , 47 (851-9).

161

Pan Z et al. A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon.
J. Neurosci., 2006 Mar 8 , 26 (2599-613).

162

Weber YG et al. Immunohistochemical analysis of KCNQ2 potassium channels in adult and developing mouse brain.
Brain Res., 2006 Mar 10 , 1077 (1-6).

163

Coppola G et al. Mutational scanning of potassium, sodium and chloride ion channels in malignant migrating partial seizures in infancy.
Brain Dev., 2006 Mar , 28 (76-9).

164

Chung HJ et al. Polarized axonal surface expression of neuronal KCNQ channels is mediated by multiple signals in the KCNQ2 and KCNQ3 C-terminal domains.
Proc. Natl. Acad. Sci. U.S.A., 2006 Jun 6 , 103 (8870-5).

165

Zhou XH et al. [A novel mutation in KCNQ2 gene causes benign familial infantile convulsions (BFIC) in a Chinese family]
Zhonghua Er Ke Za Zhi, 2006 Jul , 44 (487-91).

166

Soldovieri MV et al. Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions.
J. Biol. Chem., 2006 Jan 6 , 281 (418-28).

167

Otto JF et al. A spontaneous mutation involving Kcnq2 (Kv7.2) reduces M-current density and spike frequency adaptation in mouse CA1 neurons.
J. Neurosci., 2006 Feb 15 , 26 (2053-9).

168

Suh BC et al. Does diacylglycerol regulate KCNQ channels?
Pflugers Arch., 2006 Dec , 453 (293-301).

169

Gardiner M Molecular genetics of infantile nervous system channelopathies.
Early Hum. Dev., 2006 Dec , 82 (775-9).

170

Li HY et al. [Clinical and mutational analysis of KCNQ3 gene in a Chinese family with benign familial neonatal convulsions]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2006 Aug , 23 (374-7).

171

Schwake M et al. Structural determinants of M-type KCNQ (Kv7) K+ channel assembly.
J. Neurosci., 2006 Apr 5 , 26 (3757-66).

172

Li Y et al. Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4,5-bisphosphate.
J. Neurosci., 2005 Oct 26 , 25 (9825-35).

173

Shahidullah M et al. Expression of a calmodulin-binding KCNQ2 potassium channel fragment modulates neuronal M-current and membrane excitability.
Proc. Natl. Acad. Sci. U.S.A., 2005 Nov 8 , 102 (16454-9).

174

Schenzer A et al. Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine.
J. Neurosci., 2005 May 18 , 25 (5051-60).

175

Winks JS et al. Relationship between membrane phosphatidylinositol-4,5-bisphosphate and receptor-mediated inhibition of native neuronal M channels.
J. Neurosci., 2005 Mar 30 , 25 (3400-13).

176

Wang X et al. [Advances in the studies on the molecular and genetic aspects of epilepsy]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2005 Jun , 27 (388-93).

177

Wolff C et al. [3H]linopirdine binding to rat brain membranes is not relevant for M-channel interaction.
Eur. J. Pharmacol., 2005 Jul 25 , 518 (10-7).

178

Surti TS et al. A potassium channel, the M-channel, as a therapeutic target.
, 2005 Jul , 6 (704-11).

179

Peters HC et al. Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior.
Nat. Neurosci., 2005 Jan , 8 (51-60).

180

Surti TS et al. Identification by mass spectrometry and functional characterization of two phosphorylation sites of KCNQ2/KCNQ3 channels.
Proc. Natl. Acad. Sci. U.S.A., 2005 Dec 6 , 102 (17828-33).

181

Bassi MT et al. Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC).
Neurogenetics, 2005 Dec , 6 (185-93).

182

Shen W et al. Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons.
J. Neurosci., 2005 Aug 10 , 25 (7449-58).

183

Gamper N et al. Structural requirements for differential sensitivity of KCNQ K+ channels to modulation by Ca2+/calmodulin.
Mol. Biol. Cell, 2005 Aug , 16 (3538-51).

184

Peretz A et al. Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties.
Mol. Pharmacol., 2005 Apr , 67 (1053-66).

185

Wua YJ et al. Recent developments on KCNQ potassium channel openers.
Curr. Med. Chem., 2005 , 12 (453-60).

186

Liang G et al. An M-like potassium current in the guinea pig cochlea.
ORL J. Otorhinolaryngol. Relat. Spec., 2005 , 67 (75-82).

187

Gardiner M Genetics of idiopathic generalized epilepsies.
Epilepsia, 2005 , 46 Suppl 9 (15-20).

188

Burgess DL Neonatal epilepsy syndromes and GEFS+: mechanistic considerations.
Epilepsia, 2005 , 46 Suppl 10 (51-8).

189

Otto JF et al. Mice carrying the szt1 mutation exhibit increased seizure susceptibility and altered sensitivity to compounds acting at the m-channel.
Epilepsia, 2004 Sep , 45 (1009-16).

190

Li Y et al. Dual phosphorylations underlie modulation of unitary KCNQ K(+) channels by Src tyrosine kinase.
J. Biol. Chem., 2004 Oct 29 , 279 (45399-407).

191

Etxeberria A et al. Three mechanisms underlie KCNQ2/3 heteromeric potassium M-channel potentiation.
J. Neurosci., 2004 Oct 13 , 24 (9146-52).

192

Kelemen A et al. [Genetic background of epilepsies]
, 2004 May 20 , 57 (141-51).

193

Prole DL et al. Ionic permeation and conduction properties of neuronal KCNQ2/KCNQ3 potassium channels.
Biophys. J., 2004 Mar , 86 (1454-69).

194

Li Y et al. Single-channel analysis of KCNQ K+ channels reveals the mechanism of augmentation by a cysteine-modifying reagent.
J. Neurosci., 2004 Jun 2 , 24 (5079-90).

195

Tang B et al. A novel mutation in KCNQ2 gene causes benign familial neonatal convulsions in a Chinese family.
J. Neurol. Sci., 2004 Jun 15 , 221 (31-4).

196

Suh BC et al. Regulation of KCNQ2/KCNQ3 current by G protein cycling: the kinetics of receptor-mediated signaling by Gq.
J. Gen. Physiol., 2004 Jun , 123 (663-83).

197

Borgatti R et al. A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation.
Neurology, 2004 Jul 13 , 63 (57-65).

198

Martire M et al. M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals.
J. Neurosci., 2004 Jan 21 , 24 (592-7).

199

Devaux JJ et al. KCNQ2 is a nodal K+ channel.
J. Neurosci., 2004 Feb 4 , 24 (1236-44).

200

Avramopoulos D et al. Linkage of bipolar affective disorder on chromosome 8q24: follow-up and parametric analysis.
Mol. Psychiatry, 2004 Feb , 9 (191-6).

201

Claes LR et al. De novo KCNQ2 mutations in patients with benign neonatal seizures.
Neurology, 2004 Dec 14 , 63 (2155-8).

202

Pereira S et al. Complete loss of the cytoplasmic carboxyl terminus of the KCNQ2 potassium channel: a novel mutation in a large Czech pedigree with benign neonatal convulsions or other epileptic phenotypes.
Epilepsia, 2004 Apr , 45 (384-90).

203

Vijai J et al. Genetic association analysis of KCNQ3 and juvenile myoclonic epilepsy in a South Indian population.
Hum. Genet., 2003 Oct , 113 (461-3).

204

Hadley JK et al. Stoichiometry of expressed KCNQ2/KCNQ3 potassium channels and subunit composition of native ganglionic M channels deduced from block by tetraethylammonium.
J. Neurosci., 2003 Jun 15 , 23 (5012-9).

205

Grunnet M et al. KCNQ1 channels sense small changes in cell volume.
J. Physiol. (Lond.), 2003 Jun 1 , 549 (419-27).

206

Coppola G et al. A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes.
Neurology, 2003 Jul 8 , 61 (131-4).

207

Zhang ZH et al. Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels.
Brain Res. Mol. Brain Res., 2003 Jul 4 , 115 (29-38).

208

Gamper N et al. Subunit-specific modulation of KCNQ potassium channels by Src tyrosine kinase.
J. Neurosci., 2003 Jan 1 , 23 (84-95).

209

Schwake M et al. A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly.
EMBO Rep., 2003 Jan , 4 (76-81).

210

Guo J et al. Activation of muscarinic m5 receptors inhibits recombinant KCNQ2/KCNQ3 K+ channels expressed in HEK293T cells.
Eur. J. Pharmacol., 2003 Feb 21 , 462 (25-32).

211

Okada M et al. Age-dependent modulation of hippocampal excitability by KCNQ-channels.
Epilepsy Res., 2003 Feb , 53 (81-94).

212

Singh NA et al. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum.
Brain, 2003 Dec , 126 (2726-37).

213

Prole DL et al. Mechanisms underlying modulation of neuronal KCNQ2/KCNQ3 potassium channels by extracellular protons.
J. Gen. Physiol., 2003 Dec , 122 (775-93).

214

Gribkoff VK The therapeutic potential of neuronal KCNQ channel modulators.
Expert Opin. Ther. Targets, 2003 Dec , 7 (737-48).

215

Li HY et al. [A novel mutation of KCNQ2 gene in a Chinese family with benign familial neonatal convulsions]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2003 Dec , 20 (482-5).

216

Maljevic S et al. C-terminal interaction of KCNQ2 and KCNQ3 K+ channels.
J. Physiol. (Lond.), 2003 Apr 15 , 548 (353-60).

217

Cooper EC et al. M-channels: neurological diseases, neuromodulation, and drug development.
Arch. Neurol., 2003 Apr , 60 (496-500).

218

Yus-Nájera E et al. Localization of KCNQ5 in the normal and epileptic human temporal neocortex and hippocampal formation.
Neuroscience, 2003 , 120 (353-64).

219

Wen H et al. Calmodulin is an auxiliary subunit of KCNQ2/3 potassium channels.
J. Neurosci., 2002 Sep 15 , 22 (7991-8001).

220

Chou IC et al. The voltage-gated potassium channel KCNQ2 in Taiwanese children with febrile convulsions.
Neuroreport, 2002 Oct 28 , 13 (1971-3).

221

Shah MM et al. Molecular correlates of the M-current in cultured rat hippocampal neurons.
J. Physiol. (Lond.), 2002 Oct 1 , 544 (29-37).

222

Selyanko AA et al. Dominant-negative subunits reveal potassium channel families that contribute to M-like potassium currents.
J. Neurosci., 2002 Mar 1 , 22 (RC212).

223

Castaldo P et al. Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels.
J. Neurosci., 2002 Jan 15 , 22 (RC199).

224

Guo J et al. Activation of a PTX-insensitive G protein is involved in histamine-induced recombinant M-channel modulation.
J. Physiol. (Lond.), 2002 Dec 15 , 545 (767-81).

225

Roche JP et al. Antibodies and a cysteine-modifying reagent show correspondence of M current in neurons to KCNQ2 and KCNQ3 K+ channels.
Br. J. Pharmacol., 2002 Dec , 137 (1173-86).

226

Yus-Najera E et al. The identification and characterization of a noncontinuous calmodulin-binding site in noninactivating voltage-dependent KCNQ potassium channels.
J. Biol. Chem., 2002 Aug 9 , 277 (28545-53).

227

Guo J et al. Histamine inhibits KCNQ2/KCNQ3 channel current via recombinant histamine H(1) receptors.
Neurosci. Lett., 2002 Aug 16 , 328 (285-8).

228

Suh BC et al. Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis.
Neuron, 2002 Aug 1 , 35 (507-20).

229

Rak SG et al. Assignment of the canine potassium voltage-gated channel, KQT-like subfamily, member 3 (KCNQ3) gene to CFA 13 by radiation hybrid mapping.
Anim. Genet., 2002 Aug , 33 (320-1).

230

Steinlein OK Channelopathies can cause epilepsy in man.
, 2002 , 6 Suppl A (27-34).

231

Okada M et al. Impaired M-current and neuronal excitability.
Epilepsia, 2002 , 43 Suppl 9 (36-8).

232

Steinlein OK Genes and mutations in idiopathic epilepsy.
Am. J. Med. Genet., 2001 Summer , 106 (139-45).

233

Lerche H et al. Ion channels and epilepsy.
Am. J. Med. Genet., 2001 Summer , 106 (146-59).

234

Dedek K et al. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel.
Proc. Natl. Acad. Sci. U.S.A., 2001 Oct 9 , 98 (12272-7).

235

MacVinish LJ et al. Xe991 reveals differences in K(+) channels regulating chloride secretion in murine airway and colonic epithelium.
Mol. Pharmacol., 2001 Oct , 60 (753-60).

236

Moulard B et al. Ion channel variation causes epilepsies.
Brain Res. Brain Res. Rev., 2001 Oct , 36 (275-84).

237

Korolkova YV et al. An ERG channel inhibitor from the scorpion Buthus eupeus.
J. Biol. Chem., 2001 Mar 30 , 276 (9868-76).

238

Pan Z et al. Alternative splicing of KCNQ2 potassium channel transcripts contributes to the functional diversity of M-currents.
J. Physiol. (Lond.), 2001 Mar 1 , 531 (347-58).

239

Schrøder RL et al. KCNQ4 channel activation by BMS-204352 and retigabine.
Neuropharmacology, 2001 Jun , 40 (888-98).

240

Saganich MJ et al. Differential expression of genes encoding subthreshold-operating voltage-gated K+ channels in brain.
J. Neurosci., 2001 Jul 1 , 21 (4609-24).

241

Selyanko AA et al. Properties of single M-type KCNQ2/KCNQ3 potassium channels expressed in mammalian cells.
J. Physiol. (Lond.), 2001 Jul 1 , 534 (15-24).

242

Wickenden AD et al. Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells.
Br. J. Pharmacol., 2001 Jan , 132 (381-4).

243

Smith JS et al. Differential expression of kcnq2 splice variants: implications to m current function during neuronal development.
J. Neurosci., 2001 Feb 15 , 21 (1096-103).

244

Cooper EC et al. M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain.
J. Neurosci., 2001 Dec 15 , 21 (9529-40).

245

Tatulian L et al. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine.
J. Neurosci., 2001 Aug 1 , 21 (5535-45).

246

Robbins J KCNQ potassium channels: physiology, pathophysiology, and pharmacology.
Pharmacol. Ther., 2001 Apr , 90 (1-19).

247

Cooper EC Potassium channels: how genetic studies of epileptic syndromes open paths to new therapeutic targets and drugs.
Epilepsia, 2001 , 42 Suppl 5 (49-54).

248

Tinel N et al. M-type KCNQ2-KCNQ3 potassium channels are modulated by the KCNE2 subunit.
FEBS Lett., 2000 Sep 1 , 480 (137-41).

249

Rogawski MA KCNQ2/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy.
Trends Neurosci., 2000 Sep , 23 (393-8).

250

Haug K et al. No evidence for association between the KCNQ3 gene and susceptibility to idiopathic generalized epilepsy.
Epilepsy Res., 2000 Nov , 42 (57-62).

251

Schwake M et al. Surface expression and single channel properties of KCNQ2/KCNQ3, M-type K+ channels involved in epilepsy.
J. Biol. Chem., 2000 May 5 , 275 (13343-8).

252

Gardiner RM Impact of our understanding of the genetic aetiology of epilepsy.
J. Neurol., 2000 May , 247 (327-34).

253

Shapiro MS et al. Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+) channels that underlie the neuronal M current.
J. Neurosci., 2000 Mar 1 , 20 (1710-21).

254

Wulfsen I et al. Expression of mRNA for voltage-dependent and inward-rectifying K channels in GH3/B6 cells and rat pituitary.
J. Neuroendocrinol., 2000 Mar , 12 (263-72).

255

Kananura C et al. The new voltage gated potassium channel KCNQ5 and neonatal convulsions.
Neuroreport, 2000 Jun 26 , 11 (2063-7).

256

Wang HS et al. Molecular basis for differential sensitivity of KCNQ and I(Ks) channels to the cognitive enhancer XE991.
Mol. Pharmacol., 2000 Jun , 57 (1218-23).

257

Hirose S et al. A novel mutation of KCNQ3 (c.925T-->C) in a Japanese family with benign familial neonatal convulsions.
Ann. Neurol., 2000 Jun , 47 (822-6).

258

Lerche C et al. Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity.
J. Biol. Chem., 2000 Jul 21 , 275 (22395-400).

259

Watanabe H et al. Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability.
J. Neurochem., 2000 Jul , 75 (28-33).

260

Selyanko AA et al. Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells via M1 muscarinic acetylcholine receptors.
J. Physiol. (Lond.), 2000 Feb 1 , 522 Pt 3 (349-55).

261

Nörenberg W et al. M-type K+ currents in rat cultured thoracolumbar sympathetic neurones and their role in uracil nucleotide-evoked noradrenaline release.
Br. J. Pharmacol., 2000 Feb , 129 (709-23).

262

Hadley JK et al. Differential tetraethylammonium sensitivity of KCNQ1-4 potassium channels.
Br. J. Pharmacol., 2000 Feb , 129 (413-5).

263

Lee WL et al. A KCNQ2 splice site mutation causing benign neonatal convulsions in a Scottish family.
Neuropediatrics, 2000 Feb , 31 (9-12).

264

Schroeder BC et al. KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents.
J. Biol. Chem., 2000 Aug 4 , 275 (24089-95).

265

Main MJ et al. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.
Mol. Pharmacol., 2000 Aug , 58 (253-62).

266

Steinlein OK [Benign familial neonatal convulsions: molecular pathology and diagnosis]
, 2000 Aug , 71 (611-5).

267

Cooper EC et al. Colocalization and coassembly of two human brain M-type potassium channel subunits that are mutated in epilepsy.
Proc. Natl. Acad. Sci. U.S.A., 2000 Apr 25 , 97 (4914-9).

268

Selyanko AA et al. Two types of K(+) channel subunit, Erg1 and KCNQ2/3, contribute to the M-like current in a mammalian neuronal cell.
J. Neurosci., 1999 Sep 15 , 19 (7742-56).

269

Lerche H et al. A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions.
Ann. Neurol., 1999 Sep , 46 (305-12).

270

Omori K et al. [Molecular mechanism underlying epileptic seizure: forwards development of novel drugs for untreatable epilepsy]
Nippon Yakurigaku Zasshi, 1999 Sep , 114 (161-8).

271

Rho JM et al. Developmental seizure susceptibility of kv1.1 potassium channel knockout mice.
Dev. Neurosci., 1999 Nov , 21 (320-7).

272

McCormack T et al. Chromosomal mapping of the potassium channel genes Kcnq2 and Kcnq3 in mouse.
Genomics, 1999 Mar 15 , 56 (360-1).

273

Meves H et al. Separation of M-like current and ERG current in NG108-15 cells.
Br. J. Pharmacol., 1999 Jul , 127 (1213-23).

274

Hirsch E et al. [Benign familial neonatal convulsions: a model of idiopathic epilepsy]
Rev. Neurol. (Paris), 1999 Jul , 155 (463-7).

275

Steinlein OK et al. The voltage gated potassium channel KCNQ2 and idiopathic generalized epilepsy.
Neuroreport, 1999 Apr 26 , 10 (1163-6).

276

Steinlein OK Idiopathic epilepsies with a monogenic mode of inheritance.
Epilepsia, 1999 , 40 Suppl 3 (9-11).

277

Leppert MF et al. Susceptibility genes in human epilepsy.
, 1999 , 19 (397-405).

278

Tinel N et al. The KCNQ2 potassium channel: splice variants, functional and developmental expression. Brain localization and comparison with KCNQ3.
FEBS Lett., 1998 Nov 6 , 438 (171-6).

279

Yang WP et al. Functional expression of two KvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy.
J. Biol. Chem., 1998 Jul 31 , 273 (19419-23).

280

Charlier C et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family.
Nat. Genet., 1998 Jan , 18 (53-5).

281

Wang HS et al. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.
Science, 1998 Dec 4 , 282 (1890-3).

282

Schroeder BC et al. Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy.
Nature, 1998 Dec 17 , 396 (687-90).

283

Phillips HA et al. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2.
Nat. Genet., 1995 May , 10 (117-8).